LO

Leighanne Oh

Investor at Ascenta Capital

United States

Overview

Work Experience

  • Investor

    2024 - Current

    https://ascentacap.com/

  • Investor

    2022 - 2024

    Novo Holdings is a healthcare permanent capital fund investing in private and public companies, making it one of the most active life sciences venture capital investors globally. As of 2024, Novo Holdings was managing $147bn in total AUM with an annual capital deployment target of $3bn.

  • Investor

    2019 - 2022

    Founded in 1976, Sofinnova is a clinical-stage biopharmaceutical investment firm with approximately $3.0B in AUM and committed capital investing in both private and public equity of therapeutics-focused companies.

  • Healthcare Investment Banking

    2017 - 2019

  • Advanced Manufacturing / Operations Engineer

    2016 - 2016

    MRI Gradient Coils and Shimming Optimization

  • Investment Banking Analyst

    2014 - 2015

    https://www.linkedin.com/pulse/owen-may-mba-83-lives-his-values-through-leadership-/

  • Howard Hughes Research Fellow

    2009 - 2011

  • Research Analyst

    2010 - 2011

Relevant Websites